MEDI 242-Discovery and design of potent piperidine-based CCR5 antagonists for the potential treatment of HIV-1 infection

被引：0

作者：

Chauder, Brian A. ^{[1
]}

Anderson, Donald ^{[1
]}

Aquino, Christopher J. ^{[1
]}

Bifulco, Neil ^{[1
]}

Boone, Lawrence R. ^{[1
]}

Boros, Eric E. ^{[1
]}

Chong, Pek Y. ^{[1
]}

Du, Kien S. ^{[1
]}

Duan, Maosheng ^{[1
]}

Ferris, Robert G. ^{[1
]}

Kazmierski, Wieslaw M. ^{[1
]}

Kenakin, Terrence P. ^{[1
]}

Koble, Cecilia S. ^{[1
]}

Lang, Daniel G. ^{[1
]}

Peckham, Jennifer P. ^{[1
]}

Spaltenstein, Andrew ^{[1
]}

Thompson, James B. ^{[1
]}

Youngman, Michael K. ^{[1
]}

Wheelan, Patricia J. ^{[1
]}

机构：

[1] GlaxoSmithKline Res & Dev Ltd, Metab & Viral Dis CEDD, Durham, NC 27709 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 232卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

242-MEDI

引用

页数：1

共 50 条

[1] Discovery of potent human CCR5 antagonists for the treatment of HIV-1 infection - II.
Meurer, LC
Finke, PE
Oates, B
MacCoss, M
Mills, SG
Malkowitz, L
Springer, MS
Schleif, WA
Carella, A
Carver, G
Holmes, K
Emini, EA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U24 - U24
[2] Discovery of potent human CCR5 antagonists for the treatment of HIV-1 infection - IV.
Caldwell, CG
Chen, P
Donnelly, KF
Finke, PE
Shankaran, K
Meurer, LC
Oates, B
MacCoss, M
Mills, SG
Malkowitz, L
Springer, MS
Carella, A
Carver, G
Holmes, K
Emini, EA
Schleif, WA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U24 - U24
[3] Discovery of potent human CCR5 antagonists for the treatment of HIV-1 infection - III.
Finke, PE
Oates, B
Meurer, LC
MacCoss, M
Mills, SG
Malkowitz, L
Springer, MS
Schleif, WA
Carella, A
Carver, G
Holmes, K
Emini, EA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U24 - U24
[4] Discovery of potent human CCR5 antagonists for the treatment of HIV-1 infection - I.
Dorn, CP
Finke, PE
Oates, B
Budhu, RJ
Caldwell, CG
MacCoss, M
Mills, SG
Malkowitz, L
Springer, MS
Schleif, WA
Carella, A
Carver, G
Holmes, K
Emini, EA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U23 - U23
[5] Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection
Kim, D
Wang, LP
Caldwell, CG
Chen, P
Finke, PE
Oates, B
MacCoss, M
Mills, SG
Malkowitz, L
Gould, SL
DeMartino, JA
Springer, MS
Hazuda, D
Miller, M
Kessler, J
Danzeisen, R
Carver, G
Carella, A
Holmes, K
Lineberger, J
Schleif, WA
Emini, EA
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (24) : 3099 - 3102
[6] Discovery of potent, selective and orally active CCR5 antagonists for the potential treatment of HIV infection.
Tagat, J
McCombie, S
Nazareno, D
Steensma, R
Labroli, M
Baroudy, B
Strizki, J
Cox, K
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U175 - U175
[7] How will CCR5 antagonists influence the recommendations for the antiretroviral treatment of HIV-1 infection
van Lunzen, Jan
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) : 435 - 440
[8] CCR5 antagonists in the treatment of treatment-experienced patients infected with CCR5 tropic HIV-1
Lorenzen, Thore
Stoehr, Albrecht
Walther, Irene
Plettenberg, Andreas
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) : 419 - 425
[9] CCR5 antagonists in the treatment of treatment-naive patients infected with CCR5 tropic HIV-1
Bredeek, U. Fritz
Harbour, Michael J.
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) : 427 - 434
[10] Maraviroc - a CCR5 antagonist for the treatment of HIV-1 infection
Van Der Ryst, Elna
FRONTIERS IN IMMUNOLOGY, 2015, 6

← 1 2 3 4 5 →